About the Quantitative Imaging Network (QIN)

The Quantitative Imaging Network (QIN) promotes research, development and clinical validation of quantitative imaging tools and methods for the measurement or prediction of tumor response to therapies in clinical trial settings, with the overall goal of facilitating clinical decision making. Projects include the development and adaptation/implementation of quantitative imaging methods, imaging protocols, and software solutions/tools (used with existing commercial imaging platforms and instrumentation) and application of these methods in current and planned clinical therapy trials. The research projects focus on image-derived quantitative measurements of responses to drugs and/or radiation therapy during clinical trials or standard of care. To achieve the goals of the QIN, multidisciplinary teams which include oncologists as well as clinical and basic imaging scientists are required. The involvement of industrial partners in the development and adaptation/implementation of quantitative imaging methods to aid cancer therapies are encouraged.